NCR Online Journal

Cocaine Use Disorder Market Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies – Embera NeuroTherapeutics, Omeros, Novartis

 Breaking News
  • No posts were found

Cocaine Use Disorder Market Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies – Embera NeuroTherapeutics, Omeros, Novartis

April 24
11:33 2023
Cocaine Use Disorder Market Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032), States DelveInsight | Key Companies - Embera NeuroTherapeutics, Omeros, Novartis
DelveInsight Business Research LLP
DelveInsight’s “Cocaine Use Disorder – Market Insights, Epidemiology and Market Forecast – 2032” report delivers an in-depth understanding of the Cocaine Use Disorder, historical and forecasted epidemiology as well as the Cocaine Use Disorder market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

DelveInsight’s “Cocaine Use Disorder – Market Insights, Epidemiology and Market Forecast – 2032” report delivers an in-depth understanding of the Cocaine Use Disorder, historical and forecasted epidemiology as well as the Cocaine Use Disorder market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

 Cocaine Use Disorder Market Overview

Cocaine is a stimulant derived from the leaves of the coca plant. It is usually sold in a white powder or synthesized into crystals or rocks as “cracks.” Snorting, smoking, or injecting the drug elicits a brief euphoric, energizing, and exhilarating feeling that lasts a few minutes to an hour, followed by an unpleasant comedown. Cocaine use disorder is when a person keeps using cocaine despite the cognitive, behavioral, and physical problems it causes.

Although cocaine remains legal for medicinal use, its highly addictive potential limits its use as an anesthetic, and today it is mainly used illicitly. The drug is classified as a Schedule II narcotic by the US Drug Enforcement Agency. In addition, there is a risk of significant harm when cocaine is taken with alcohol, heroin, and other substances. One of the most frequent and severe consequences of cocaine use is overdose, which can cause heart attacks and strokes that can be deadly. In normal instances, the brain releases dopamine in response to possible rewards, such as the smell of good food, then cycles back into the cell that released it and shuts off the signal between nerve cells. However, in cocaine use, dopamine is prevented from recycling, which causes extra amounts to build up between nerve cells. Because of this “flood” of dopamine, normal brain communication is interrupted and causing the high that people get from cocaine.

Learn more about the Cocaine Use Disorder  market @ Cocaine Use Disorder Market Landscape

Cocaine Use Disorder Epidemiological Segmentation 

  • Cocaine Use Disorder prevalent cases 

  • Cocaine Use Disorder gender specific prevelant cases 

  • Cocaine Use Disorder diagnosed cases   

  • Cocaine Use Disorder treatable cases 

Cocaine Use Disorder Market Outlook 

Cocaine is among the major illicit stimulants used worldwide. There is an increased risk of dependence with heavier use and when cocaine is smoked or injected. Additionally, cocaine abuse is associated with significant mortality and morbidity with cardiovascular and neurologic effects, and chronic repeated exposure leads to tolerance, adverse psychological and behavioral effects, and complications, including infections, stroke, and seizure. However, no medication has yet been approved to treat CUD; psychosocial treatment is currently the standard.

Several psychological treatments, including group counseling, individual drug counseling, cognitive behavioral therapy (CBT), and contingency management, are effective; however, many patients still do not respond to these treatments and are associated with high dropout rates. Despite decades of efforts, CUD has not responded well to pharmacotherapeutic interventions. Nevertheless, a significant understanding of neurobiology has led to the discovery of potential medications like dopamine agonists, including long-acting amphetamine, modafinil, and ?-aminobutyric acid (GABA)/glutamatergic medications, including topiramate. A few combination medications, such as topiramate and mixed amphetamine salts, also appear promising.

Key Companies in the Cocaine Use Disorder Market Include:

  • Embera NeuroTherapeutics

  • Omeros 

  • Novartis 

  • Catalyst Pharmaceuticals 

  • Eilly Lilly 

  • Somerset Pharmaceuticals 

And many others  

Cocaine Use Disorder Therapies Covered and Analyzed in the Report:

  • AFQ056

  • NS2359

  • RBP-8000 100 mg

  • Selegiline

  • Vigabatrin

  • Buprenorphine 

And many others 

Learn more about the Cocaine Use Disorder Market Key Companies and Emerging Therapies 

Table of Contents

  1. Key Insights 

  2. Cocaine Use Disorder  Report Introduction 

  3. Executive Summary of the Cocaine Use Disorder  Market  

  4. Cocaine Use Disorder  Disease Background and Overview

  5. Cocaine Use Disorder  Epidemiology and patient population

  6. Cocaine Use Disorder  Market Emerging Therapies

  7. Cocaine Use Disorder  Market Drivers 

  8. Cocaine Use Disorder  Market Barriers 

  9. Market Access and Reimbursement of Therapies

  10. Appendix

  11. Report Methodology

  12. DelveInsight Capabilities

  13. Disclaimer

  14. About DelveInsight

Learn more about the detailed report offerings @ Cocaine Use Disorder Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services